The University of Tokyo―one of Japan’s Foremost Academic Institutions

• The University of Tokyo is top in Japan and among the world leading institutions in number of papers published, citation counts, and the citation rate.Reference →
• Research conducted by the University of Tokyo accounts for more than 10% of the Grant-in-Aid for Scientific Research program administrated by the Ministry of Education, Culture, Sports, Science and Technology.Reference →
• The University of Tokyo’s TR-related research seeds include several hundred projects spanning a wide range of treatment fields.
• The University has made a firm commitment to the TR Initiative―the program is overseen by the Committee for Presidential Initiatives. Reference →
• The scope of the TR Initiative extends to departments and laboratories conducting TR-related research, and in addition to drugs includes medical devices, regenerative medicine, and research on platform technologies for medical applications.Reference →

Single Point of ContactReference →

The TR Initiative is UTokyo’s main contact point for TR related to regenerative medicine.

• We encourage businesses to address any related requests or enquiries regarding this field to the TR Initiative.
• Please feel free to enquire about any matter, from specific projects to general questions.
• The TR Initiative will also convey any messages or announcements from businesses to UTokyo researchers (both to specific individuals and the general research faculty).
• The TR Initiative will also convey any messages or requests from UTokyo researchers to businesses.
• We also promote the cooperation between the researchers across more than ten Faculties, Institutes and University-wide Centers in The University of Tokyo.
• If you have established existing connections with other UTokyo departments or faculty members, you may continue to communicate through these channels.

TR Initiative contact point:

Comprehensive Research Mapping System

• The TR Initiative comprehensively identifies TR-related research conducted at the university (SEEDS research).
  • Regular surveys of SEEDS research are conducted, and the database is updated (generally twice per year)
  • Using the results of these SEEDS research surveys, data sheets for each SEEDS research and each researcher are created, maintained, and managed.
    Reference: for SEEDS research →Reference: for Researcher →
  • This data covers all attributes required to ascertain SEEDS research content.

• The TR Initiative aims to build a system that enables SEEDS research matching the needs and interests of our corporate partners to be easily extracted from the vast SEEDS research data on file (Research Mapping System).Reference →
  • Research Mapping System functions allow SEEDS research data to be extracted according to combinations of attributes.
  • This makes it possible to locate the required (desired) SEEDS research via the internet, easily and instantly.

The TR Initiative increases the success rate of TR projects by applying strategic TR know-how to innovative academic research.

• The TR Initiative has established a Steering and Science Committee (SSC).
  • The SSC is comprised of professionals with a wealth of experience in health care companies, including R&D (fundamental, clinical and pharmacological research), intellectual property, licensing, and organizational management. The Committee includes medical patent attorneys, former regulatory professionals, business consultants (temporary), and legal advisors.Reference →
  • By providing the necessary specialist advice and support to TR projects from their early stages, the SSC works to ensure that translational research delivers the results required by businesses.Reference →
  • The SSC has established strict internal rules regarding conflict of interest, and will not maintain direct contact with businesses involved in the TR Initiative.